Internal Medicine, Endocrinology, Diabetes, & Metabolism · Modesto, CA
NPI
1841256948
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 524-1211
Groups this clinician bills Medicare through
Medicare paid, 2024
$472K
17,543 services
Medicare patients, 2024
1,017
Average age 73
Drug cost, 2024
$4.7M
12,698 prescriptions
Company payments, 2025
$200
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nirali Patel was code J0897 (injection, denosumab, 1 mg), 14,220 times for 182 patients. In total Nirali Patel billed 17,543 services in 18 codes, and Medicare paid $472K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 14,220 | 182 | $20.46 | $291K |
| 99214 Office E&M - Established | Office | 1,558 | 876 | $89.72 | $140K |
| 96372 Injection Administration | Office | 243 | 183 | $11.62 | $2,823 |
| 99204 Office E&M - New | Office | 176 | 176 | $124.42 | $22K |
| 83036 Blood Count | Office | 60 | 55 | $9.52 | $571 |
| 99213 Office E&M - Established | Office | 27 | 26 | $63.39 | $1,712 |
| 95251 Test - Miscellaneous | Office | 15 | 15 | $27.58 | $414 |
| 99215 Office E&M - Established | Office | 13 | 13 | $112.72 | $1,465 |
By year: 2022 $450K for 19,301 services; 2023 $508K for 23,727 services; 2024 $472K for 17,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 60 | 55 | $9.52 | $571 |
Medicare prescription drug claims, 2024
In 2024, the drug Nirali Patel prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 1,052 prescriptions and refills. In total Nirali Patel wrote 12,698 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 1,052 | 1,739 | 218 | $982K |
| Levothyroxine Sodium Generic | 874 | 2,257 | 235 | $10K |
| Ozempic Semaglutide | 804 | 1,103 | 159 | $1.0M |
| Atorvastatin Calcium Generic | 528 | 1,426 | 164 | $4,609 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 490 | 1,165 | 156 | $73K |
| Metformin Hcl Generic | 486 | 1,334 | 154 | $3,936 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 349 | 819 | 140 | $40K |
| Lisinopril Generic | 317 | 876 | 101 | $2,065 |
| Tresiba Flextouch U-100 Insulin Degludec | 296 | 543 | 74 | $199K |
| Rosuvastatin Calcium Generic | 289 | 756 | 91 | $7,999 |
| Humalog Kwikpen U-100 Insulin Lispro | 287 | 471 | 96 | $86K |
| Trulicity Dulaglutide | 264 | 355 | 59 | $337K |
| Mounjaro Tirzepatide | 251 | 292 | 63 | $300K |
| Metformin Hcl Er Metformin Hcl | 248 | 691 | 83 | $2,654 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 246 | 474 | 79 | $22K |
Brand drugs: 6,150 claims; generic drugs: 5,414 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nirali Patel $200 ($200 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novo Nordisk Inc with $115.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.